Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter P Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Talal El Zarif, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet A Bilen
BACKGROUND: COVID-19 can have a particularly detrimental effect on patients with cancer, but no studies to date have examined if the presence, or site, of metastatic cancer is related to COVID-19 outcomes. METHODS: Using the COVID-19 and Cancer Consortium (CCC19) registry, the authors identified 10,065 patients with COVID-19 and cancer (2325 with and 7740 without metastasis at the time of COVID-19 diagnosis). The primary ordinal outcome was COVID-19 severity: not hospitalized, hospitalized but did not receive supplemental O2 , hospitalized and received supplemental O2 , admitted to an intensive care unit, received mechanical ventilation, or died from any cause...
February 20, 2024: Cancer